Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality

Peter C Arnold
Med J Aust 2010; 192 (2): . || doi: 10.5694/j.1326-5377.2010.tb03437.x
Published online: 18 January 2010

To the Editor: The general practitioners’ dilemma is acute. Women asking for mammography and/or testing for ovarian cancer; men asking for prostate-specific antigen (PSA) testing for prostate cancer. The debate, fuelled by uncertain knowledge, rages in the general medical journals,1,2 including contributions in the 17 August 2009 issue of the MJA.3,4

  • Peter C Arnold

  • Sydney, NSW.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.